| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/05/1997 | CN1144489A Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
| 03/04/1997 | US5607954 Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals |
| 03/04/1997 | US5607952 Substituted 4-phenylthiazole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/04/1997 | US5607944 Bicyclic heterocyclic compounds, pharmaceutical preparations containing these compounds and processes for their preparations |
| 03/04/1997 | US5607937 Piperazides of substituted phenylalanine derivatives as thrombin inhibitors |
| 03/04/1997 | US5607917 Methods for reducing blood loss |
| 03/04/1997 | US5607858 Pentapeptides or hexapeptide amides for diagnosis and anticoagulants |
| 03/04/1997 | US5607694 Forming sealant by mixing virus inactivated fibrinogen and thrombin, liposomes with entrapped medicaments deliverable in wound or opening, and calcium; thrombin promotes fibrin clot formation, liposomes release medicaments |
| 03/01/1997 | CA2184226A1 Pharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its use |
| 02/27/1997 | DE19531342A1 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren Use of aminoadamantane compounds as immune regulators |
| 02/27/1997 | DE19530996A1 Cyclische Guanidine, Verfahren zu ihrer Herstellung und Arzneimittel Cyclic guanidines, methods for their preparation and pharmaceutical |
| 02/26/1997 | EP0758905A1 Pharmaceutical compositions comprising hirudin |
| 02/26/1997 | EP0630382B1 Lactam dipeptides having hle inhibiting activity |
| 02/26/1997 | EP0519976B1 Neutrophil stimulating peptides |
| 02/26/1997 | CN1143969A Compositions and methods using unbound mpl receptor for stimulating platelet production |
| 02/26/1997 | CN1143950A Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure |
| 02/26/1997 | CN1143894A Macrophage inflammatory proteins-3,-4 and -1 r |
| 02/25/1997 | US5606086 Heat resistant carbonate-and/or bicarbonate-iron-lactoferrin complex |
| 02/25/1997 | US5605930 Compositions and methods for treating and preventing pathologies including cancer |
| 02/25/1997 | US5605893 Mixture of carbohydrates, protein and fats |
| 02/25/1997 | US5605696 Drug loaded polymeric material and method of manufacture |
| 02/25/1997 | US5605689 Treatment of HIV-associated immune thrombocytopenic purpura |
| 02/20/1997 | WO1997005861A1 Calcium-containing agent for intestinal phosphate binding and process for producing it |
| 02/20/1997 | CA2213773A1 Imidazopyridine derivatives |
| 02/19/1997 | EP0758648A1 Substituted 4H-pyrans with a modulating effect on calcium channels |
| 02/19/1997 | EP0758341A1 FACTOR Xa INHIBITORS |
| 02/19/1997 | EP0758248A1 Formulations for factor ix |
| 02/19/1997 | EP0758226A1 Red blood cell surrogate |
| 02/19/1997 | CN1143372A Haemopoietic manuration factor |
| 02/19/1997 | CN1143363A Isoxazoline compounds as inhibitors of TNF release |
| 02/19/1997 | CN1143323A Bicyclic fibrinogen antagonists |
| 02/18/1997 | US5604225 Dietetics; obesity |
| 02/18/1997 | US5604207 Sialyl Lex analogues as inhibitors of cellular adhesion |
| 02/18/1997 | US5604116 Interleukin-3 (IL-3) multiple mutation polypeptides, recombinant production of the same, and corresponding therapeutic methods |
| 02/18/1997 | US5604103 Kit for detection of clinical marker in kidney stone disease |
| 02/18/1997 | US5603943 Physiologically active substance homogeneously dispersed in and adsorbed on polyvalent metal carrier of specified particle size |
| 02/15/1997 | CA2183048A1 Substituted 4h-pyrans |
| 02/13/1997 | WO1997005154A1 Improved therapeutic agents |
| 02/13/1997 | WO1997004779A1 Quinolones and their therapeutic use |
| 02/13/1997 | WO1997004768A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | WO1996013583A3 Targeted hetero-association of recombinant proteins to multi-functional complexes |
| 02/13/1997 | CA2228298A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | CA2225552A1 Quinolones and their therapeutic use |
| 02/12/1997 | EP0757719A1 $g(a)-1-ANTICHYMOTRYPSIN ANALOGUES HAVING CHYMASE INHIBITING ACTIVITY |
| 02/12/1997 | EP0757718A1 Methods of use of uncoated gel particles |
| 02/12/1997 | EP0544681B1 A novel salicylic acid-maltol conjugates |
| 02/12/1997 | CN1142833A Poly-beta-1-4-N-acetylglucosamine |
| 02/12/1997 | CN1142831A Novel 2-substituted indane-2-mercaploacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 02/12/1997 | CN1142776A Hirudin conjugates from hirudin and lipophilic compounds |
| 02/12/1997 | CN1142495A Platelet activating factor antagonist and preparation thereof |
| 02/12/1997 | CN1142393A Preparation and usage of reducing viscosity Chinese medicine capsule |
| 02/11/1997 | US5602253 Peptides derivatives |
| 02/11/1997 | US5602233 Activation and deactivation |
| 02/11/1997 | US5602155 Platelet aggregation inhibitors |
| 02/11/1997 | US5602149 1-OXO-2-(phenylsulphonylamino)pentypiperidine derivatives, their preparation and their therapeutic application |
| 02/11/1997 | US5602145 Anticoagulants |
| 02/11/1997 | US5602144 Thienopyridones |
| 02/11/1997 | US5601804 Antiplaque agent |
| 02/11/1997 | CA2045605C Treatment of leukocyte dysfunction with gm-csf |
| 02/11/1997 | CA2034546C 1, 3-dicarbonyl compounds and their use |
| 02/06/1997 | WO1997004097A2 Human ctla-8 and uses of ctla-8-related proteins |
| 02/06/1997 | WO1997003663A1 NON-β-OXIDIZABLE FATTY ACID ANALOGUES, THEIR USES AS THERAPEUTIC ACTIVE MEDICAMENTS, AND PREPARATION THEREOF |
| 02/06/1997 | DE19528524A1 Calciumhaltiges Mittel zur intestinalen Phosphatbindung und Verfahren zu seiner Herstellung Calcium-containing phosphate binding agents for intestinal and process for its preparation |
| 02/06/1997 | CA2227220A1 Human ctla-8 and uses of ctla-8-related proteins |
| 02/06/1997 | CA2226871A1 Non-.beta.-oxidizable fatty acid analogues, their uses as therapeutic active medicaments, and preparation thereof |
| 02/05/1997 | EP0756638A1 Method and means for detecting and treating disorders in the blood coagulation cascade |
| 02/05/1997 | EP0616642B1 New thrombin-inhibiting proteins from terrestrial leeches |
| 02/05/1997 | CN1142227A Novel thiazolidin-4-one derivatives |
| 02/05/1997 | CN1142189A Platelet-special chimeric immunoglobulin and methods of use thereof |
| 02/05/1997 | CN1141809A Method for treatment of undissolved thrombus acute myocardinal infraction by using hirudin and acetylsalicylic acid |
| 02/04/1997 | US5599975 Cyclised analogues of fatty acid metabolites |
| 02/04/1997 | US5599909 Process for reactivating purified membrane proteins |
| 02/04/1997 | US5599817 Administering 8-/3-oxocyclopentyl/-1,3-di-n-propyl-7h-purine-2,6-dione to stimulate diuresis |
| 02/04/1997 | US5599801 Formed by nitrous depolymerization of heparin; low molecular weight |
| 02/04/1997 | US5599793 Anticoagulants |
| 02/04/1997 | US5599678 Antibodies which react with fibrinogen fragments E1, E2 and E3 and methods of their use |
| 01/30/1997 | WO1997003084A1 New inhibitors of platelet aggregation |
| 01/30/1997 | WO1997003072A1 New oxazolidinone derivatives, process for preparing the same and medicaments that contain these compounds |
| 01/30/1997 | WO1997003069A1 Heterocyclic compounds and pharmaceutical compositions containing them |
| 01/30/1997 | CA2226758A1 New inhibitors of platelet aggregation |
| 01/30/1997 | CA2225411A1 New oxazolidinone derivatives, processes for the production thereof and pharmaceutical agents containing these compounds |
| 01/29/1997 | EP0756005A1 Gene coding for adseverins |
| 01/29/1997 | EP0755263A1 Compositions and methods for stimulating megakaryocyte growth and differentiation |
| 01/29/1997 | EP0656777B1 Ready-to-inject azosemide solutions |
| 01/29/1997 | CN1141637A Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/29/1997 | CN1141625A Vitamin D amine and amine derivatives |
| 01/29/1997 | CN1141592A Pharmaceutical prepn. contg. plasminogen activators |
| 01/29/1997 | CN1141590A Agent for prophylaxis and treatment of thromboxane A2-mediated diseases |
| 01/29/1997 | CN1141291A 4-(Arylaminomethylene)-2,4-dihydro-3-pyrazolones |
| 01/28/1997 | US5597833 Leukotriene synthesis inhibitors for antiinflammatory agents, respiratory system disorders, antiallergens or antiischemic agents |
| 01/28/1997 | US5597804 N-sulfonylarginine keto-amide compounds |
| 01/28/1997 | US5597711 Factor VIII binding domain of von Willebrand factor |
| 01/28/1997 | US5597562 Oral dosage form of biologically active proteins |
| 01/23/1997 | WO1997002284A1 New thrombin inhibitors, their preparation and use |
| 01/23/1997 | WO1997002037A1 Compounds and pharmaceutical compositions containing them |
| 01/23/1997 | WO1997002024A1 Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis |
| 01/23/1997 | WO1996040743A3 Inhibitors of factor xa |
| 01/23/1997 | WO1996040073A3 Composition for sustained release of non-aggregated erythropoietin |
| 01/23/1997 | CA2225666A1 Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis |
| 01/23/1997 | CA2225391A1 Compounds and pharmaceutical compositions containing them |